Our results identify MYC/PVT1 amplification and PVT1 translocation as key drivers of cancer pathogenesis, reshaping the oncogenic signaling landscape through the expression—or lack thereof—of previously uncharacterized short proteins. The gene discussed is PVT1; the disease is cancer.